As of 2026-09-22, the Relative Valuation of Recursion Pharmaceuticals Inc (RXRX) is (24.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.97 USD, the upside of Recursion Pharmaceuticals Inc based on Relative Valuation is -722.8%.
The range of the Relative Valuation is (23.79) - (23.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.3x - 29.4x | 26.8x |
| Forward P/E multiples | 22.9x - 24.4x | 23.6x |
| Fair Price | (23.79) - (23.89) | (24.72) |
| Upside | -699.4% - -701.8% | -722.8% |
| Date | P/E |
| 2026-09-21 | -4.05 |
| 2026-09-18 | -3.91 |
| 2026-09-17 | -3.62 |
| 2026-09-16 | -3.26 |
| 2026-09-15 | -3.31 |
| 2026-09-14 | -3.48 |
| 2026-09-11 | -3.27 |
| 2026-09-10 | -3.23 |
| 2026-09-09 | -3.28 |
| 2026-09-08 | -3.51 |
| 2026-09-04 | -3.71 |
| 2026-09-03 | -3.51 |
| 2026-09-02 | -3.45 |
| 2026-09-01 | -3.40 |
| 2026-08-31 | -3.47 |
| 2026-08-28 | -3.41 |
| 2026-08-27 | -3.51 |
| 2026-08-26 | -3.56 |
| 2026-08-25 | -3.64 |
| 2026-08-24 | -3.32 |
| 2026-08-21 | -3.57 |
| 2026-08-20 | -3.41 |
| 2026-08-19 | -3.57 |
| 2026-08-18 | -3.16 |
| 2026-08-17 | -3.18 |
| 2026-08-14 | -3.23 |
| 2026-08-13 | -3.38 |
| 2026-08-12 | -3.36 |
| 2026-08-11 | -3.42 |
| 2026-08-10 | -3.36 |
| 2026-08-07 | -3.29 |
| 2026-08-06 | -3.25 |
| 2026-08-05 | -3.24 |
| 2026-08-04 | -3.38 |
| 2026-08-03 | -3.25 |
| 2026-07-31 | -3.06 |
| 2026-07-30 | -3.10 |
| 2026-07-29 | -3.03 |
| 2026-07-28 | -3.11 |
| 2026-07-27 | -3.07 |
| 2026-07-24 | -3.02 |
| 2026-07-23 | -3.07 |
| 2026-07-22 | -3.04 |
| 2026-07-21 | -3.15 |
| 2026-07-20 | -2.95 |
| 2026-07-17 | -3.01 |
| 2026-07-16 | -3.08 |
| 2026-07-15 | -3.38 |
| 2026-07-14 | -3.41 |
| 2026-07-13 | -3.37 |